SETD1A and neurodevelopmental disorder: In this context, future studies should comprehensively investigate whether upregulated cAMP/PKA signaling caused by SETD1A haploinsufficiency also applies to other brain regions or other cell types related to SCZ or neurodevelopmental disorders, such as serotonergic (Carvajal-Oliveros and Campusano, 2021) or dopaminergic neurons (Eells, 2003) and glial cells (Blanco-Suárez et al., 2017).